Canadian radiation oncology firm MDS Nordion has received Food and Drug Administration 510(k) clearance for Dose Modelling (DM), an independent dose-calculation software program for inverse planning of intensity-modulated radiation therapy (IMRT). Dose Modelling is the first module in the vendor's vision for what it calls distributed treatment planning, a suite of independent treatment planning modules that can integrate into an open oncology information system.
DM communicates with external-beam radiation treatment planning systems using DICOM RT objects, according to the Ottawa, Ontario-based company. Currently used with MDS Nordion's Theraplan Plus treatment planning system, DM runs on a desktop workstation using the Windows 2000 operating system. More than 100 hospitals and cancer clinics worldwide will receive DM for their Theraplan Plus systems, according to MDS Nordion.
By AuntMinnie.com staff writersJune 12, 2001
Copyright © 2001 AuntMinnie.com
